2022 Fall Conference | C6 - Neurology Update 3: Neuromuscular Disease and Adolescent/Child Neurology for the Adult Neurologist

Date Friday 10/28/22

Time 01:00 PM - 02:30 PM PDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Laurie Gutmann, MD, FAAN

Topic(s) Child Neurology and Developmental Neurology, Neuromuscular and Clinical Neurophysiology (EMG)

Learning Objectives Neuromuscular: Discuss advancements in immunotherapy for myasthenia gravis; Discuss new approved drug for amyotrophic lateral sclerosis (ALS); Discuss gene-based therapeutics for ALS, spinal muscular atrophy, familial transthyretin neuropathy
Adolescent/Child Neurology: This lecture should improve the confidence of adult practitioners in caring for children with neurodevelopmental differences and complex congenital disorders with increased survival into adulthood.

CME Available 1.50 CME credits

Core Competencies Medical Knowledge

Program Level Intermediate

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student

Teaching Styles Didactic

Program Materials

Event Timeline
01:00 PM - 01:45 PM PDT	Speaker	Neuromuscular Disease Leo H. Wang, MD, PhD, FAAN
01:45 PM - 02:30 PM PDT	Speaker	Adolescent/Child Neurology for the Adult Neurologist Madeline A. Chadehumbe, MD, FAAN

Faculty Disclosures
Laurie Gutmann, MD, FAAN	The institution of Dr. Gutmann has received research support from NIH. The institution of Dr. Gutmann has received research support from Harmony . Dr. Gutmann has received publishing royalties from a publication relating to health care.
Leo H. Wang, MD, PhD, FAAN	Dr. Wang has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AskBio. Dr. Wang has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Fulcrum Therapeutics. Dr. Wang has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Wang has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Tanabe. Dr. Wang has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx. Dr. Wang has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Avidity. Dr. Wang has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB Pharma. Dr. Wang has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lupin. Dr. Wang has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sarepta. Dr. Wang has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Scholar Rock. The institution of Dr. Wang has received research support from National Institute of Health. Dr. Wang has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant with US Government.
Madeline A. Chadehumbe, MD, FAAN	Dr. Chadehumbe has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Nobias.

��ɫ��

��ɫ��